Selasa, 09 Juni 2026 - 20:33 WIB

Find and Follow Us

Global Markets

IHSG 5,746.65 +7.57%

S&P 500 7,446.49 +0.55%

NASDAQ 25,929.66 +0.00%

Dow Jones 50,937.00 +0.30%

FTSE 100 10,335.53 -0.36%

CAC 40 8,272.42 +0.89%

Nikkei 225 65,416.63 +2.17%

Hang Seng 24,565.90 -0.37%

Shanghai 4,010.03 +1.28%

KOSPI 8,096.93 +8.18%

STI 5,023.25 +1.20%

ASX 200 8,604.20 -0.24%

Sensex 73,918.76 +0.54%

Gold 4,358.50 +0.52%

Silver 68.56 +0.20%

Oil (WTI) 88.94 -2.58%

Brent 92.25 -2.12%

Copper 6.44 +1.71%

Gas Alam 3.15 +0.00%

Bitcoin 62,295.90 -1.26%

Ethereum 1,669.53 -1.22%

USD/IDR 18,050.00 +0.12%

EUR/USD 1.16 +0.46%

Advertisement

Ilustrasi Vaksin Covid-19 (Photo by Lifestyle - Bisnis.com)

Kritisi Pendirian Pabrik Vaksin China di RI, DPR: Pemerintah Harusnya Prioritaskan Vaksin Merah Putih

Redaksi • 25 Agustus 2021

Latest Updates

- Advertisement -

Ilustrasi Vaksin Covid-19 (Photo by Lifestyle - Bisnis.com)

16:45 WIB • 25 Agustus 2021

Kritisi Pendirian Pabrik Vaksin China di RI, DPR: Pemerintah Harusnya Prioritaskan Vaksin Merah Putih

Jakarta-Anggota Komisi VII DPR RI Mulyanto mengkritisi pemerintah yang lebih mengutamakan pendirian pabrik vaksin dari China…